To the Editor: In the Placebo-Controlled Efficacy in iNPH Shunting (PENS) trial, Luciano et al. (Dec. 4 issue) 1 investigated the effectiveness of shunting in participants with idiopathic ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

The risk for endophthalmitis in patients with glaucoma who undergo drainage procedures appears to persist for at least 5 years after the initial operation, a new research showed. The findings, from ...

Timothy Graham receives funding from the Australian Research Council (ARC) for the Discovery Project, 'Understanding and Combatting "Dark Political Communication"'. A new study published today in ...

People often blame social media algorithms that prioritize extreme content for increasing political polarization, but this effect has been difficult to prove. Only the platform owners have access to ...

Elon Musk's social network X (formerly known as Twitter) last night released some of the code and architecture of its overhauled social recommendation algorithm under a permissive, enterprise-friendly ...

As movies have morphed from a vibrant public event into a product we watch on our personal screens, film criticism has also been disrupted thanks to apps like Letterboxd. Fortunately, film critic A. S ...

BEIJING, Dec 27 (Reuters) - China's cyber regulator on Saturday issued draft rules for public comment that would tighten oversight of artificial intelligence services designed to simulate human ...

Meta is giving Instagram users a rare glimpse into why certain posts are showing up on their Reels, the platform’s feed of algorithmically curated videos. Starting today, users will now see a list of ...

Retention analysts say Shorts older than 28-30 days are being deprioritized in recommendations. The reported shift affects channels ranging from 100 million to one billion monthly views. Creators warn ...

Uncertainties about efficacy and longer-term safety with the Ventura interatrial shunt system (V-Wave, a Johnson & Johnson company) doomed the technology when vetted by a US Food and Drug ...